The scientist’s investigation covers issues in Esophagus, Internal medicine, Barrett's esophagus, Dysplasia and Gastroenterology. His study in Esophagus focuses on Esophageal disease in particular. His work on Incidence, GASTRIC CARDIA and Peptic ulcer as part of his general Internal medicine study is frequently connected to Osteoarthritis, thereby bridging the divide between different branches of science.
His study in Barrett's esophagus is interdisciplinary in nature, drawing from both MEDLINE, Esophageal cancer, Biopsy, General surgery and Endoscopy. His Dysplasia research includes themes of Surgery, Esophagectomy, Endoscopic mucosal resection, Carcinoma and Adenocarcinoma. His research in Gastroenterology intersects with topics in Severity of illness and Confidence interval.
Gary W. Falk mainly focuses on Internal medicine, Gastroenterology, Barrett's esophagus, Esophagus and Dysplasia. His work on Eosinophilic esophagitis, Cancer, Esophageal adenocarcinoma and GERD as part of general Internal medicine research is frequently linked to In patient, bridging the gap between disciplines. His work carried out in the field of Gastroenterology brings together such families of science as Esophageal cancer, Incidence, Cohort study and Disease.
His Barrett's esophagus research is multidisciplinary, incorporating elements of Surgery, Intestinal metaplasia, Radiofrequency ablation, Radiology and General surgery. His study looks at the intersection of Esophagus and topics like Adenocarcinoma with Risk factor. His Dysplasia study incorporates themes from Metaplasia, Esophagectomy, Endoscopic mucosal resection, Confidence interval and Carcinoma.
Gary W. Falk spends much of his time researching Internal medicine, Gastroenterology, Eosinophilic esophagitis, Barrett's esophagus and Esophagus. The Esophageal adenocarcinoma, Eosinophilic gastritis, Randomized controlled trial and Cohort research Gary W. Falk does as part of his general Internal medicine study is frequently linked to other disciplines of science, such as In patient, therefore creating a link between diverse domains of science. His Gastroenterology study deals with Placebo-controlled study intersecting with Histological response.
The study incorporates disciplines such as Biopsy, Dysplasia, General surgery and GERD in addition to Barrett's esophagus. The Dysplasia study combines topics in areas such as Adenocarcinoma and Hazard ratio. His Esophagus study also includes fields such as
Gary W. Falk mostly deals with Internal medicine, Gastroenterology, Eosinophilic esophagitis, Esophagus and Barrett's esophagus. His Gastroenterology research incorporates themes from Multicenter study, Proportional hazards model, Placebo-controlled study and Antibody, SIGLEC. The various areas that Gary W. Falk examines in his Eosinophilic esophagitis study include Eosinophil, Budesonide, Eosinophilic, Esophagogastroduodenoscopy and Dysphagia.
The study incorporates disciplines such as Odds ratio, Epithelium, Cancer research, Intestinal metaplasia and Endoscopy in addition to Esophagus. His Barrett's esophagus study frequently intersects with other fields, such as Dysplasia. His Dysplasia study incorporates themes from Metaplasia and Adenocarcinoma.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
Chris A. Liacouras;Glenn T. Furuta;Ikuo Hirano;Dan Atkins.
The Journal of Allergy and Clinical Immunology (2011)
Radiofrequency Ablation in Barrett's Esophagus with Dysplasia
Nicholas J Shaheen;Prateek Sharma;Bergein F. Overholt;Herbert C. Wolfsen.
The New England Journal of Medicine (2009)
ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus
Nicholas J Shaheen;Gary W Falk;Prasad G Iyer;Lauren B Gerson.
The American Journal of Gastroenterology (2016)
A critical review of the diagnosis and management of Barrett’s esophagus: the AGA Chicago Workshop
Prateek Sharma;Kenneth McQuaid;John Dent;M. Brian Fennerty.
web science (2004)
Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial
Peter J Kahrilas;G. W. Falk;D. A. Johnson;C. Schmitt.
Alimentary Pharmacology & Therapeutics (2000)
The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: Report on the cleveland clinic barrett's esophagus registry
J B O'Connor;G W Falk;J E Richter.
The American Journal of Gastroenterology (1999)
Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus.
Prateek Sharma;Gary W. Falk;Allan P. Weston;Dean Reker.
Clinical Gastroenterology and Hepatology (2006)
The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease
Joseph J. Vicari;Richard M. Peek;Gary W. Falk;John R. Goldblum.
Durability of Radiofrequency Ablation in Barrett's Esophagus With Dysplasia
Nicholas J Shaheen;Bergein F. Overholt;Richard E. Sampliner;Herbert C. Wolfsen.
Consensus Statements for Management of Barrett's Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi Process
Cathy Bennett;Nimish Vakil;Jacques Bergman;Rebecca Harrison.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: